Evidence map›Paper›PMID 37378557›Full record

ArticleCancer discovery2023

Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.

Juyeun Lee, Michael Nicosia, Ellen S Hong, Daniel J Silver, Cathy Li, Defne Bayik, Dionysios C Watson, Adam Lauko, Kristen E Kay, Sabrina Z Wang and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer discovery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
21.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Sex-Biased Immunity: The Hidden Variable in Immuno-oncology.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  10. Article
  11. Article
  12. Sex Differences in Colorectal Tumor-Associated T-cell Responses.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Juyeun LeeDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0001-8276-5020
Michael NicosiaDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0003-2295-0763
Ellen S HongDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-5299-4217
Daniel J SilverDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-7085-2626
Cathy LiDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0009-0002-4924-4439
Defne BayikDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-4740-8869
Dionysios C WatsonDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-9146-5641
Adam LaukoDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0001-5654-0784
Kristen E KayDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-4459-6454
Sabrina Z WangDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-5541-7327
Sadie JohnsonDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0001-5250-9835
Mary McGrawRose Ella Burkhardt Brain Tumor Center, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-8406-8541
Matthew M GrabowskiRose Ella Burkhardt Brain Tumor Center, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0001-8550-0124
Danielle D KishDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0009-0000-0121-229X
Amar B DesaiCase Comprehensive Cancer Center, Cleveland, Ohio.ORCID 0000-0001-8649-6630
Wendy A GoodmanDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio.ORCID 0000-0002-6864-0384
Scott J CameronDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-9616-1540
Hideho OkadaDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California.ORCID 0000-0003-0076-9920
Anna ValujskikhDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0003-3252-0636
Robert L FairchildDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-7107-5259
Manmeet S AhluwaliaMiami Cancer Institute, Miami, Florida.ORCID 0000-0003-3794-9511
Justin D LathiaDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0003-3168-7290
Cleveland Clinic Lerner College of Medicine · USCleveland Clinic · USCase Comprehensive Cancer CenterCase Western Reserve University · USUniversity Hospitals of Cleveland · USUniversity of California, San Francisco · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Sex-specific differences in the tumor microenvironment alter glioblastoma growthP01CA245705 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI Daniel J Silver · 2020 to 2026
$15.0M
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Preclinical development of breakthrough immunotherapy for brain tumorsR35NS105068 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OKADA, HIDEHO · 2018 to 2025
$6.0M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
TRAINING IN GEOGRAPHIC MEDICINE &INFECTIOUS DISEASET32AI007024 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 1985 to 2020
$4.5M
Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in GlioblastomaR35NS127083 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI Justin D. Lathia · 2022 to 2026
$3.1M
NRSA Training CoreTL1TR002549 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2018 to 2022
$2.9M
Platelets as Biosensors and Mediators of Aortic Aneurysm GrowthR01HL158801 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI CAMERON, SCOTT JAMES · 2021 to 2025
$2.5M
Estrogen-mediated immune regulation in human and experimental inflammatory bowel diseaseR01DK128143 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI GOODMAN, WENDY ANN · 2021 to 2025
$2.2M
Deciphering MDSC function for GBM targetingR01NS109742 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI LATHIA, JUSTIN D., VOGELBAUM, MICHAEL A. · 2019 to 2023
$1.7M
Mitochondrial transfer from astrocytes to glioblastoma cells drives tumor growthR00CA277242 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Dionysios C Watson · 2024 to 2026
$632k
NCATS NIH HHS TL1 TR002549NCI NIH HHS F30 CA250254NCI NIH HHS F31 CA264849NCI NIH HHS K99 CA248611NCI NIH HHS K99 CA277242NCI NIH HHS P01 CA245705NCI NIH HHS R00 CA277242NHLBI NIH HHS 75N92020D00005NHLBI NIH HHS R01 HL158801NIAID NIH HHS 75N93022D00005NIAID NIH HHS 75N93023D00005NIAID NIH HHS T32 AI007024NIDA NIH HHS 75N95020D00005NIDDK NIH HHS R01 DK128143NIGMS NIH HHS T32 GM007250NINDS NIH HHS R01 NS109742NINDS NIH HHS R35 NS105068NINDS NIH HHS R35 NS127083ORFDO NIH HHS 75N99020D00005
6 · The paper itself

Abstract

Sex differences in glioblastoma (GBM) incidence and outcome are well recognized, and emerging evidence suggests that these extend to genetic/epigenetic and cellular differences, including immune responses. However, the mechanisms driving immunologic sex differences are not fully understood. Here, we demonstrate that T cells play a critical role in driving GBM sex differences. Male mice exhibited accelerated tumor growth, with decreased frequency and increased exhaustion of CD8+ T cells in the tumor. Furthermore, a higher frequency of progenitor exhausted T cells was found in males, with improved responsiveness to anti-PD-1 treatment. Moreover, increased T-cell exhaustion was observed in male GBM patients. Bone marrow chimera and adoptive transfer models indicated that T cell-mediated tumor control was predominantly regulated in a cell-intrinsic manner, partially mediated by the X chromosome inactivation escape gene Kdm6a. These findings demonstrate that sex-biased predetermined behavior of T cells is critical for inducing sex differences in GBM progression and immunotherapy response. SIGNIFICANCE: Immunotherapies in patients with GBM have been unsuccessful due to a variety of factors, including the highly immunosuppressive tumor microenvironment in GBM. This study demonstrates that sex-biased T-cell behaviors are predominantly intrinsically regulated, further suggesting sex-specific approaches can be leveraged to potentially improve the therapeutic efficacy of immunotherapy in GBM. See related commentary by Alspach, p. 1966. This article is featured in Selected Articles from This Issue, p. 1949.

Indexed as

Brain NeoplasmsGlioblastomaAnimalsCD8-Positive T-LymphocytesFemaleImmunityImmunotherapyMaleMiceT-Cell ExhaustionTumor Microenvironment

Identifiers

PMID37378557
PMCPMC10481130
OpenAlexW4382344675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.